STAT+

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Business Bob Herman

STAT Plus: Biden administration to recalculate Medicare Advantage quality ratings and bonuses

Biotech Meghana Keshavan

STAT Plus: FDA gets pointed input on ‘optimizing’ advisory committee panels

Business Mohana Ravindranath and Katie Palmer

STAT Plus: Telehealth startup Done’s top leadership arrested on fraud charges

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Does Sanders have the votes to subpoena a Novo exec?

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Pfizer drug for Duchenne, bird flu vaccines for cows, and more

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: Will Geron be acquired? The long-short view

Pharma Andrew Joseph

STAT Plus: Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried

Pharma Jason Mast

STAT Plus: Pfizer’s gene therapy for Duchenne muscular dystrophy fails in Phase 3 trial

Exclusive Brittany Trang

STAT Plus: New AI for biopsies can analyze microscopy images, talk to pathologists about your tumor

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Sanders dogging Novo Nordisk, Teva patents, and more

Biotech Jason Mast

STAT Plus: Avidity Biosciences says its experimental drug showed potential against form of muscular dystrophy

Business Casey Ross and Mohana Ravindranath

STAT Plus: Why Google and Microsoft can’t defuse U.S. health care’s ticking cybersecurity problem

Health tech Brittany Trang

STAT Plus: Google’s Verily to offer GLP-1 drugs through Lightpath, its retooled chronic care app

Pharmalot Andrew Joseph

STAT Plus: Pharmalittle: We’re reading about Lilly’s Alzheimer’s drug, an EU contract for bird flu vaccine, and more

Biotech Allison DeAngelis

STAT Plus: Biotech co-founded by entrepreneur Bob Langer is testing a new approach to developing obesity treatments

Health tech Timmy Broderick

STAT Plus: Tweezers? Wrenches? Researchers plot prosthetics’ future with tools, not hands

Biotech Elaine Chen and Adam Feuerstein

STAT Plus: FDA advisers unanimously recommend approval of Eli Lilly’s Alzheimer’s disease treatment

Health Care Inc. Bob Herman

STAT Plus: Humana scores a win in a Medicare Advantage case

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Moderna Covid-flu vaccine, a paused Pfizer study, and more

Health tech Mohana Ravindranath

STAT Plus: Teladoc has a new CEO, but challenges remain the same

Biotech Helen Branswell

STAT Plus: Moderna says data show its combination Covid-flu vaccine generates a strong immune response

In the Lab Timmy Broderick

STAT Plus: Watch: How Harvard researchers boosted an ALS patient’s independence with a box and a balloon

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Jason Mast

STAT Plus: Pharmalittle: We’re reading about Lilly’s Alzheimer’s drug, the GSK-Elsie deal, and more

In the Lab Jonathan Wosen

STAT Plus: Stephen Quake on the Chan Zuckerberg quest to cure, prevent, or manage all diseases by 2100

Biotech Jonathan Wosen and Meghana Keshavan

STAT Plus: At BIO, signs Congress’ tough stance on China is chilling biotech relationships

Business Bob Herman

STAT Plus: Cigna wins case to block former executive from jumping to CVS

Biotech Matthew Herper and Elaine Chen

STAT Plus: FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted to a smaller group